GlassScriptPhysician profile
Patrick Joseph Shanahan
NPI 1275512253
$6,628.52
in general payments reported to CMS, 2019-2025
38 companies · $657 in 2025
The $657 reported for 2025 was more than what 78% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $911 · 2020: $857 · 2021: $1,289 · 2022: $965 · 2023: $1,139 · 2024: $810 · 2025: $657.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,593 · Education: $13.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,592.74 |
| Education | $13.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $932.84 | 2019-2025 | Evenity, Repatha, Otezla |
| Lilly USA, LLC | $866.52 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Pfizer INC. | $549.80 | 2019-2025 | |
| Astellas Pharma US INC | $496.42 | 2019-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $454.69 | 2021-2025 | Ubrelvy, Vraylar |
| Boehringer Ingelheim Pharmaceuticals, INC. | $433.29 | 2019-2024 | Jardiance, Tradjenta |
| Amarin Pharma, INC. | $273.16 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $262.70 | 2019-2025 | Gardasil 9, Capvaxive, Gardasil |
| Otsuka America Pharmaceutical, INC. | $260.07 | 2021-2024 | Rexulti, Nuedexta |
| Exact Sciences Corporation | $229.62 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Glaxosmithkline, LLC. | $220.73 | 2019-2023 | Trelegy Ellipta, Shingrix, Arexvy |
| Novo Nordisk INC | $211.35 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Janssen Pharmaceuticals, INC | $186.80 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $150.39 | 2020-2025 | Eliquis |
| Allergan, INC. | $120.65 | 2020 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Shanahan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.